Crossmark

Recent advances in treatment of follicular lymphoma: efficacy of PI3Kα/δ inhibitor (TQ-B3525)

Crossref DOI link: https://doi.org/10.1038/s41392-024-01842-z

Published Online: 2024-05-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Watanabe, Takuya https://orcid.org/0000-0003-3820-0262
License Information

Text and Data Mining valid from 2024-05-16

Version of Record valid from 2024-05-16
More Information

Article History

Received: 27 March 2024

Revised: 5 April 2024

Accepted: 24 April 2024

First Online: 16 May 2024

Competing interests

: The author declares no competing interests.